Cough: A Comprehensive Guide for MCCQE1 Preparation
Introduction
Cough is one of the most common presenting complaints in primary care in Canada. For the MCCQE1, candidates must demonstrate the ability to differentiate between benign, self-limiting causes and serious underlying pathology. As a Medical Expert under the CanMEDS framework, you are expected to apply a structured approach to diagnosis and management, adhering to Canadian Thoracic Society (CTS) guidelines.
Definition: A cough is a protective reflex mechanism that clears the airways of secretions and foreign bodies. It can be voluntary or involuntary and involves an afferent limb (vagus nerve), a central cough center (medulla), and an efferent limb.
Classification of Cough
The most clinically useful classification for the MCCQE1 is based on duration. This temporal framework narrows the differential diagnosis significantly.
Acute (< 3 weeks)
Acute Cough
- Duration: Less than 3 weeks.
- Most Common Etiology: Viral Upper Respiratory Tract Infection (URTI).
- Other Causes: Acute bronchitis, Pneumonia, Exacerbation of COPD/Asthma, Foreign body aspiration, Pulmonary Embolism (PE), Acute Heart Failure.
Clinical Evaluation
History Taking (Data Acquisition)
For the MCCQE1, efficient history taking is paramount. You must identify Red Flags early.
🚩 Red Flags (Alarm Symptoms)
- Hemoptysis: Suggests malignancy, TB, PE, or bronchiectasis.
- Significant Weight Loss: Suggests malignancy or chronic infection (TB).
- Fever/Night Sweats: Suggests infection (TB, abscess) or lymphoma.
- Dyspnea (at rest or exertional): Suggests COPD, HF, ILD.
- Hoarseness: Recurrent laryngeal nerve involvement (malignancy).
- Heavy Smoking History (>20 pack-years): High risk for malignancy/COPD.
- Abnormal Chest X-ray: Any consolidation or mass.
Key Questions to Ask:
- Onset and Duration: Acute vs. Chronic.
- Sputum: Colour, volume, presence of blood.
- Triggers: Cold air, exercise (Asthma), lying flat (GERD/Heart Failure), eating (Aspiration/GERD).
- Associated Symptoms: Nasal congestion (UACS), heartburn (GERD), wheeze (Asthma).
- Medications: specifically ACE Inhibitors (up to 15% of patients; can occur months after initiation).
- Social History: Smoking (pack-years), occupational exposures (asbestos, silica), travel history (TB endemic areas).
Physical Examination
Focus on the respiratory and cardiovascular systems, plus the upper airway.
| System | Key Findings to Look For | Significance |
|---|---|---|
| General | Clubbing, Cachexia | Malignancy, Bronchiectasis, ILD |
| HEENT | Cobblestoning of oropharynx, nasal polyps | UACS, Allergic Rhinitis |
| Neck | Lymphadenopathy, Tracheal deviation | Malignancy, Infection |
| Lungs | Wheezes | Asthma, COPD |
| Crackles (Rales) | Pneumonia, Heart Failure, ILD | |
| Focal decreased breath sounds | Pleural effusion, Pneumothorax | |
| Cardio | JVP elevation, S3 gallop | Heart Failure |
Diagnostic Approach: The MCCQE1 Algorithm
Follow this step-by-step approach, aligned with Canadian Thoracic Society (CTS) guidelines for Chronic Cough.
Step 1: Rule out Red Flags & Environmental Causes
Perform a history and physical. If red flags are present, proceed immediately to Chest X-ray (CXR) and targeted workup. If the patient is a smoker, advise cessation. If on an ACE Inhibitor, stop the medication and observe for 4 weeks.
Step 2: Chest X-ray (CXR)
A CXR is indicated for almost all patients with chronic cough (> 8 weeks).
- Abnormal CXR: Investigate specific pathology (e.g., CT chest, bronchoscopy).
- Normal CXR: Proceed to Step 3 (Evaluation of the “Big Three”).
Step 3: Evaluate Common Causes (“The Big Three”)
In a non-smoking patient with a normal CXR and no ACE-I use, 90% of chronic coughs are due to:
- UACS: Trial of intranasal steroids or antihistamine/decongestant.
- Asthma: Spirometry (PFTs) with bronchodilator reversibility. If normal but suspicion remains high, consider Methacholine Challenge Test.
- GERD: Trial of PPI and lifestyle modification (Note: Cough may take 3 months to resolve).
Step 4: Investigate Less Common Causes
If the above are negative or treatment fails:
- Non-Asthmatic Eosinophilic Bronchitis (NAEB): Diagnosis requires induced sputum analysis for eosinophils (>3%). Treatment: Inhaled corticosteroids.
- Pertussis: Nasopharyngeal swab/PCR.
Step 5: Unexplained Chronic Cough
If all investigations are negative, the diagnosis is “Unexplained Chronic Cough.” Referral to a respirologist is indicated.
Canadian Guidelines & Epidemiology
Canadian Thoracic Society (CTS) Guidelines
The CTS emphasizes a systematic approach. A key differentiator in Canadian guidelines is the management of Pertussis.
- Pertussis (Whooping Cough): Endemic in Canada with periodic outbreaks.
- Suspect in adults with > 2 weeks of cough, especially if paroxysmal, associated with vomiting, or inspiratory whoop.
- Public Health: It is a reportable disease in Canada.
Tuberculosis (TB) Screening
Canada has a low incidence of TB, but rates are higher in:
- Foreign-born individuals from endemic countries.
- Indigenous populations (First Nations, Inuit, Métis).
- Homeless populations.
- MCCQE1 Tip: Have a low threshold for ordering a CXR and sputum AFB in these demographics if presenting with chronic cough.
Environmental Exposures
Be aware of Canadian occupational hazards:
- Grain dust: Farmers lung.
- Mining: Silicosis (common in parts of Northern Ontario/Quebec).
Key Points to Remember for MCCQE1
- ACE Inhibitors: Cough is a class effect. Angiotensin Receptor Blockers (ARBs) do not cause cough and are a safe alternative.
- Cough Variant Asthma: Asthma where cough is the only symptom. Spirometry may be normal; Methacholine challenge is the gold standard for diagnosis.
- UACS: The most common cause of chronic cough in non-smokers. Look for “cobblestoning” on the posterior pharynx.
- Red Flags: Hemoptysis + Smoker + Age > 55 = High suspicion for Lung Cancer. CT Chest is often the next best step after CXR.
- Code Block for Abbreviations:
UACS = Upper Airway Cough Syndrome GERD = Gastroesophageal Reflux Disease NAEB = Non-asthmatic Eosinophilic Bronchitis ACE-I = Angiotensin-Converting Enzyme Inhibitor CXR = Chest X-Ray PFT = Pulmonary Function Test
Sample Question
Clinical Scenario
A 42-year-old female presents to your family medicine clinic with a persistent dry cough for the past 3 months. She reports a sensation of “something dripping” down the back of her throat and frequent throat clearing. She is a non-smoker and takes no medications. She has no history of asthma or heartburn. Physical examination reveals a normal chest auscultation, but inspection of the oropharynx shows a cobblestone appearance of the posterior pharyngeal mucosa. A chest X-ray performed last week was normal.
Question
Which one of the following is the most appropriate initial management step for this patient?
- A. Prescribe a trial of a proton pump inhibitor (PPI).
- B. Order a Methacholine Challenge Test.
- C. Prescribe a first-generation antihistamine and decongestant.
- D. Order a CT scan of the chest.
- E. Prescribe a course of oral antibiotics.
Explanation
The correct answer is:
- C. Prescribe a first-generation antihistamine and decongestant.
Detailed Explanation: This patient presents with a chronic cough (> 8 weeks) with specific symptoms and signs pointing towards Upper Airway Cough Syndrome (UACS), formerly known as post-nasal drip. The key features are the sensation of dripping, throat clearing, and the cobblestone appearance of the oropharynx (lymphoid hyperplasia).
- Option C is correct: According to Canadian Thoracic Society guidelines, in a non-smoker with a normal CXR and clinical features suggestive of UACS, an empiric trial of therapy is the appropriate next step. First-generation antihistamines (e.g., chlorpheniramine) combined with a decongestant are often effective for non-allergic UACS. If allergic rhinitis is suspected, intranasal corticosteroids are preferred.
- Option A is incorrect: While GERD is a top cause of chronic cough, this patient has no symptoms of reflux (heartburn), and the physical findings point strongly to UACS.
- Option B is incorrect: This would be appropriate if Cough Variant Asthma was the primary suspicion (e.g., nocturnal cough, triggers like cold air), but UACS is more likely given the pharyngeal findings.
- Option D is incorrect: A CT chest is not indicated as the initial step for a patient with a normal CXR and a high probability of a benign “Big Three” cause.
- Option E is incorrect: Antibiotics are not indicated for chronic cough unless there is evidence of bacterial infection (e.g., sinusitis, pneumonia), which is not present here.
References
- Canadian Thoracic Society (CTS). Guideline: Management of Cough in Adults and Children. Available at cts-sct.ca .
- Medical Council of Canada. Objectives for the Qualifying Examination (MCCQE) Part I.
- Irwin RS, et al. Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines. Chest.
- UpToDate. Evaluation of subacute and chronic cough in adults. (Accessed for current best practices).